Clinical Trial Update: Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating olmesartan with an add-on therapy in adults with mild to moderate essential hypertension; the study has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Sankyo Pharma Gmbh | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-11-10